MDCG 2026-5 Draws the Line Between Manufacturer and Distributor

MedTech Leading Voice | Issue 175

📝 From the Editor

Four of this week's posts touch UDI, and two cover the same new MDCG 2026-5 guidance on who assigns the identifier when a device moves from manufacturer to distributor. Traceability has stopped being a data-entry task and become a question about who owns the record.

— Sean Smith

🧠 Featured Post

MDCG 2026-5 guidance on UDI assignment between manufacturers and distributors

Hatem Rabeh detailed MDCG 2026-5, the new guidance covering UDI assignment responsibilities for manufacturers and distributors. It sets out which party carries the obligation to assign the UDI-DI.

For MedTech teams, this is the week's most concrete compliance item. Elevate MedTech covered the same guidance from the manufacturer side, and Tibor Zechmeister's walkthrough of UDI fundamentals and their role in MDR traceability sits underneath it. If you sell through distributors or private-label partners, the assignment question is worth settling before your next registration.

View the post >>

📌 This Week's Top Posts (In no special order)

• EU MDR Compliance shared a practical cheat sheet covering the fundamentals of post-market surveillance under the MDR.
• The IEC 60601-1 4th edition timeline and current standards development progress were outlined by Leonard Eisner.
• Harriet Kamendi examined the early development decisions that can strengthen or weaken a 510(k) submission.
• EU Battery Regulation requirements for replaceable batteries in medical devices were explained by Beat Keller.
• Erik van Dijk compared FDA and EU MDR approaches to product changes after initial market clearance.
• In her weekly Monday News, Marina Daineko summarized recent FDA and EU regulatory updates impacting biocompatibility, IVDs, and UDI requirements.
• Tibor Zechmeister broke down the fundamentals of UDI and its role in MDR medical device traceability.
• MDCG 2026-5 guidance on UDI assignment responsibilities for manufacturers and distributors was detailed by Hatem Rabeh.
• Alexander J. Wurzer revealed the evolving role of intellectual property in AI-enabled medical devices.
• FDA's authentication recommendations for medical device cybersecurity underscored by Jose Bohorquez.
• Tatiana D. highlighted the role of EN 18286 in helping AI-enabled medical devices align with upcoming EU AI Act requirements.
• JDL Access explored the fundamentals of medical device reimbursement and market access support.
• Manufacturer responsibilities for UDI-DI assignment under MDCG 2026-5 were clarified by Elevate MedTech.

🎯 Featured Event

Beyond the Protocol: A Realistic Resource and Planning Guide for Human Factors Validation Success

Ask a manager how long a Human Factors Validation takes and you may hear "you ran the sessions, just write up the data." Anyone who has run one knows the report is where the work happens. Root cause analysis, clear links to use-related risk, and evidence a reviewer can follow.

Denise Forkey and Leya Bergquist of ClariMed are joined by Kira Favakeh of Medtronic for what HF Validation actually requires: how to set a credible timeline, prepare the study team, decide where added investment prevents expensive rework, and make the case to the people who control the budget. They will also take the question that comes up most, which is what to do when the schedule will not move.

Thursday, August 6, 2026 at 11:00 AM ET. Live online, recording sent to all registrants.

Register Now >>

🗓️ Upcoming Events & Webinars

• Friday, August 7, 2026 | 11:00 AM ET — FDA 510(k) Cybersecurity Power Hour: Demystifying Cybersecurity Controls in 60 Minutes, featuring Jose Bohorquez, PhD, CEO of CyberMed, and Mohamad Foustok, Chief Security Officer at CyberMed. Friday In-Focus runs like a live technical podcast. Jose and Mohamad work through FDA's eight Appendix 1 categories and where reasonable-looking decisions turn into expensive security, testing, or remediation work later. Registrants get Jose's Appendix 1 guide. Register Now >>
• Wednesday, August 19, 2026 | 11:00 AM ET — When Enrollment Stops: Diagnosing a Study That's Already Gone Wrong, featuring Daniela Karrer (Donawa Lifescience). Register Now >>
• Wednesday, August 26, 2026 | 8:00 AM–5:00 PM ET — Project Medtech Startup Symposium, Quorum at the Science Center, Philadelphia, in collaboration with Penn Health-Tech. RSVP >>

💥 Weekly 510(k) Roundup

July 27, 2026 | From Marcus Engineering, LLC

72 clearances this week, including 27 first-time clearances (🚀).

Featured first-time clearances:

• 🚀 Sounduct— Ossiclear (Ear, Nose, Throat): a bone conduction hearing device that rests against the side of the head and converts sound into vibrations that travel through the skull to the inner ear. Nothing sits inside the ear canal, which gives an option to people who cannot benefit from conventional hearing aids.
• 🚀 Total Flow Medical— Femoral Arterial Cannula (Cardiovascular): used when a machine temporarily circulates blood outside the body. The cannula splits the flow, delivering oxygen-rich blood both toward the heart and brain and to the rest of the body.
• 🚀 EyeKon Medical, Inc. — QuickSet TKP™ (Ophthalmic): a temporary artificial cornea used during complex eye surgery. When injury or disease clouds the eye's natural window, QuickSet restores visibility so surgeons can repair the eye before removing the device and completing the procedure.

Explore the update >>

📋 Regulatory Roundup

Monday, 27 July 2026 | By Martin King

Clinical Research Modernisation, Regulatory Convergence and Digital Governance Define This Week's Global Regulatory Landscape

Martin's read is that this week's publications keep pushing toward risk-based, internationally harmonised, and digitally enabled regulation. He points to developments in ICH E6(R3), clinical trials, Good Manufacturing Practice, Health Technology Assessment, regulatory reliance, AI governance, and cybersecurity as evidence that regulators are folding clinical governance, quality management, digital transformation, and lifecycle oversight into their frameworks.

His priority list for organisations: GCP implementation, quality management systems, regulatory intelligence, submission quality, regulatory reliance, AI and cybersecurity governance, and continuous lifecycle compliance. He singles out clinical research modernisation, pharmaceutical quality, regulatory convergence, risk-based regulation, and global harmonisation as the capabilities becoming fundamental expectations across pharmaceuticals, medical devices, and IVDs.

Explore the update >>

🎤 In Case You Missed It

Designing Electronic Medical Devices That Actually Reach Production

André DiMino ran an unusually interactive Friday In-Focus session on designing electronic devices for production. Audience polls surfaced where programs most often run into trouble, and participants added their own cases involving obsolete components, electrical-safety failures, poor production yield, materials, testing, and cybersecurity. The lesson underneath all of it: manufacturability decisions made early determine whether a working prototype can be produced consistently, compliantly, and at a viable cost.

Watch the replay >> | Get André's slides >>

🔥 Postscript

The Project Medtech Startup Symposium is at Quorum at the Science Center in Philadelphia on August 26, in collaboration with Penn Health-Tech. Use code MLV20 for 20% off.

RSVP >>

Sean 🐝